user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 438267 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

Highest Sales per Share in the Biotechnology Industry Detected for Biogen Idec (BIIB, AMGN, UTHR)

Published on Thu, 02/07/2013 - 11:25
By Robert Cotter

Below are the three companies in the Biotechnology industry with the highest sales per share. Sales per share is a valuable metric in comparing relative value for companies in the same industry.

Biogen Idec (NASDAQ:BIIB) is highest with sales per share of $23.19. Biogen Idec Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis.

Biogen Idec (NASDAQ:BIIB) is currently priced 0.7% above its average consensus analyst price target of $159.90. The stock should discover initial support at its 50-day moving average (MA) of $149.44 and subsequent support at its 200-day MA of $144.14.

Amgen (NASDAQ:AMGN) is next with sales per share of $22.28.

Finishing up the top three is United Therapeutics (NASDAQ:UTHR), with sales per share of $16.38.

By Robert Cotter
rcotter@fnno.com